Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cereport and Carboplatin in Childhood Brain Tumors
NCT00019422Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Mar 1998
- Modality
- Small Molecules
- Countries
- 7
01
Overview
Phase 2, open-label, single-arm trial of lobredimil in brain tumor, glioma, medulloblastoma and 4 more, sponsored by National Cancer Institute. Primary endpoint: Objective Response Rate. Started Mar 1998; status: completed.
02
Drugs
lobredimil
03
Conditions
brain tumorgliomamedulloblastomaprimitive neuroectodermal tumor (PNET)ependymoma
Beyond the preview
Go deeper on NCT00019422.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00019422.